US Patent 12116355 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

121163550

Patent Inventor Names

Klaus Gjervig Jensen0

Peter Hongaard Andersen0

Morten Jorgensen0

Date of Patent

October 15, 2024

Patent Application Number

173402010

Date Filed

June 7, 2021

Patent Citations

‌

US Patent 7648991 Crystalline base of

‌

US Patent 7678914 Deuterated benzo[

‌

US Patent 7767683 Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament

‌

US Patent 7772240 None

‌

US Patent 7863274 Deuterium enriched analogues of tadalafil as PDE5 inhibitors

‌

US Patent 8076342 Malonate salt of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same

‌

US Patent 8263601 Deuterium substituted xanthine derivatives

‌

US Patent 8278460 Substituted benzimidazoles

...

Patent Primary Examiner

‌

John S Kenyon

Patent abstract

The present invention relates to deuterated 1-piperazino-3-phenyl-indanes and salts thereof with activity at dopamine receptors D

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 12116355 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 12116355 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia